Advertisement

Omega-3 Fatty Acids and Lipoproteins

  • T. A. B. Sanders

Abstract

There are five major classes of lipids in blood: free fatty acids, phospholipids, triglycerides, cholesterol esters and free cholesterol. Lipids are generally insoluble in aqueous solution and need to be bound to proteins to facilitate their transport. Free fatty acids are transported in the blood bound to albumen, the other lipids are carried by the plasma lipoproteins. The plasma lipoproteins are lipid — protein complexes of density d < 1.21g/ml. They are classified in terms of their hydrated density, as determined in the preparative ultracentrifuge. Four classes of lipoprotein particles are present in the plasma of normal fasting human subjects: very low density lipoprotein (VLDL) d < 1.006g/ml, intermediate density lipoprotein (IDL) d 1.006–1.019g/ml, low density lipoprotein (LDL) d 1.019–1.063 g/ml and high density lipoprotein (HDL) d > 1.063 g/ml. Particles of a fifth class, the chylomicrons (d < 1.006g/ml), appear in the plasma a few hours after a fatty meal and are gradually cleared from the circulation.

Keywords

Plasma Phospholipid Intermediate Density Lipoprotein High Density Lipoprotein Cholesterol Concentration European Atherosclerosis Society Hypertriglyceridaemic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    European Atherosclerosis Society, Strategies for the prevention of coronary heart disease: a policy statement by the European Atherosclerosis Society, Eur. Hrt. J. 8: 77–88 (1987).Google Scholar
  2. 2.
    H.O. Bang and J. Dyerberg, Lipid metabolism in Greenland Eskimos, Adv. Nutr. Res te 3: 1–40 (1980).CrossRefGoogle Scholar
  3. 3.
    T.A.B. Sanders and D.R. Sullivan, J. Reeve, and G.R. Thompson, Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia, Arteriosclerosis 5: 459–465 (1985).PubMedCrossRefGoogle Scholar
  4. 4.
    T.A.B. Sanders and F. Roshanai, The influence of different types of w3 fatty polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers, Clin,. Sci. 64: 91–99 (1983).Google Scholar
  5. 5.
    F. Roshanai and T.A.B. Sanders, Influence of different supplements of n-3 polyunsaturated fatty acids on blood and tissue lipids in rats receiving high intakes of linoleic acid, Ann. Nutr. Metab. 29; 189–196 (1985).PubMedCrossRefGoogle Scholar
  6. 6.
    T.A.B. Sanders, Fish and coronary artery disease, Br. Hrt. J. 57: 214–219 (1987).Google Scholar
  7. 7.
    S. Rogers, J.S. James, B.K. Butland, M.D. Etherington, J.R. O’Brien and J.G. Jones, Effects of fish oil supplement on serum lipid, blood pressure, bleeding time and rheological variables. A double blind randomised controlled trial in healthy volunteers, Atherosclerosis 63, 137–143 (1987).PubMedCrossRefGoogle Scholar
  8. 8.
    D.R. Illingworth, W.R. Harris, and W.E. Connor, Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans, Arteriosclerosis 4: 270–275 (1984).PubMedCrossRefGoogle Scholar
  9. 9. P.J. Nestel, Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol, Am. J. clin. Nutr. 43: 752–757 (1986).Google Scholar
  10. 10.
    D.R. Sullivan, T.A.B. Sanders, I.M. Trayner,I.M. and G.R. Thompson, Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil, Atherosclerosis 61: 129–134 (1986).PubMedCrossRefGoogle Scholar
  11. 11.
    D.M. Demke, G.R. Peter, O.I. Linet, C.M. Metzler, and K.A. Klott, Effects of a fish oil concentrate in patients with hypercholesterolaemia, Atherosclerosis 70, 73–80 (1988).PubMedCrossRefGoogle Scholar
  12. 12.
    A.P. Haines,A.P., T.A.B. Sanders, J.D. Imerson, et al., Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics, Thromb. Res. 43: 643–655 (1986).Google Scholar
  13. 13.
    R. Vandongen, T.A. Mori, J.P. Codde, K.G. Stanton,K.G. and J.R.L. Maserei, Hypercholesterolaemic effect of fish oil in insulin dependent diabetic patients, Med. J, Aus. 148: 141–143 (1988).Google Scholar
  14. 14.
    S. Wong,S., and P.J. Neste!, Eicosapentaenoic acid inhibits the secretion of triacylglycerol and of apoprotein B and the binding of LDL in Hep G2 cells, Atherosclerosis 64: 139–146 (1987).Google Scholar
  15. 15.
    B.E. Phillipson, D.W. Rothrock, W.E. Connor, W.S.Harris, and D.R. Illingworth, Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia, N. Eng. J. Med. 19: 1210–1216 (1985).CrossRefGoogle Scholar
  16. 16.
    Y.A. Kesaniemi, W.F. Beltz, and S.M. Grundy, Comparison of clofibrate and caloric restriction on kinetics of very low density lipoprotein triglycerides, Arteriosclerosis 5: 153–161 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • T. A. B. Sanders
    • 1
  1. 1.Department of Food and Nutritional SciencesKing’s College, University of LondonLondonUK

Personalised recommendations